PULM

Pulmatrix, Inc. is a clinical-stage biopharmaceutical firm based in Lexington, Massachusetts, specializing in the development of inhaled therapies aimed at treating respiratory diseases and serious conditions with significant unmet medical needs. Leveraging its proprietary inhalation drug delivery technologies, the company is advancing a robust pipeline of innovative treatments designed to improve patient outcomes and enhance quality of life. With a strategic commitment to key therapeutic areas, Pulmatrix is well-positioned to be a crucial contributor in the dynamic field of respiratory medicine.